In line with this, immunoreactivity for apoA-I, apoB, or SR-BI was associated with the differentiation of renal carcinomas into ccRCC as well as with tumor grade (apoA-I and apoB) or tumor stage (apoB). Here, APOB is linked to renal carcinoma.